Location History:
- Wayland, MA (US) (2009)
- Ledyard, CT (US) (2015)
Company Filing History:
2 out of 4,456 
1 out of 24 
Years Active: 2009-2015
Title: The Innovations of Carrie L. Melvin
Introduction
Carrie L. Melvin is a noteworthy inventor based in Ledyard, Connecticut, with a focus on groundbreaking advancements in cancer treatment and diagnostics. With two patents to her name, her contributions to the field showcase her dedication to improving patient outcomes and facilitating new methods for cancer screening and therapy.
Latest Patents
Carrie Melvin holds two significant patents that highlight her innovative approach to medical technology. The first, titled "Circulating Tumor Cell Assay," discloses methods for detecting, enumerating, and analyzing circulating tumor cells expressing insulin-like growth factor-1 receptors (IGF-1R). These methods are instrumental in cancer screening and staging, development of treatment regimens, and monitoring treatment responses, as well as cancer recurrence. Additionally, this patent provides test kits that simplify the detection and analysis of such circulating tumor cells.
Her second patent, "Combination Treatment for Non-Hematologic Malignancies," introduces a therapeutic method for treating non-hematologic cancers. This involves administering anti-IGF-1R antibodies alongside other therapeutic agents. The invention further includes pharmaceutical compositions containing these antibodies and outlines methods for using these compositions in treatment.
Career Highlights
Throughout her career, Carrie has contributed her expertise to notable companies, including Pfizer Corporation and Veridex, LLC. Her work in these reputable organizations has allowed her to spearhead innovative projects that align with her focus on enhancing cancer diagnostics and treatment strategies.
Collaborations
Carrie has collaborated with distinguished professionals in the field, such as Antonio Gualberto and Bruce D. Cohen. These collaborations reflect her commitment to working with others to advance cancer research and therapy, fostering a collaborative environment that promotes innovation.
Conclusion
Carrie L. Melvin's innovations have made significant strides in cancer research and treatment. Her patents reflect her dedication to improving diagnostic methods and developing effective therapies, offering hope to patients facing non-hematologic malignancies. As a prominent figure in her field, her work continues to inspire future advancements in medical technology.